Michael F. Herfs

CHU Sart Tilman B23, 13 Hippocrate Avenue
Liege, WAL 4000, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 80 publications

Turning off methylglyoxal stress: an alternative approach to inhibit MDSC expansion and metastasis in triple-negative breast cancer.

Turning off methylglyoxal stress: an alternative approach to inhibit MDSC expansion and metastasis in triple-negative breast cancer.

Journal: Journal for immunotherapy of cancer

Published: June 26, 2026

Clonal origin and early lineage divergence in adenosquamous carcinoma.

Clonal origin and early lineage divergence in adenosquamous carcinoma.

Journal: Cell reports

Published: January 20, 2026

Pathophysiology of cutaneous commensal human papillomaviruses.

Pathophysiology of cutaneous commensal human papillomaviruses.

Journal: The Journal of investigative dermatology

Published: November 28, 2025

Correction: Methylglyoxal, a glycolysis metabolite, triggers metastasis through MEK/ERK/SMAD1 pathway activation in breast cancer.

Correction: Methylglyoxal, a glycolysis metabolite, triggers metastasis through MEK/ERK/SMAD1 pathway activation in breast cancer.

Journal: Breast cancer research : BCR

Published: June 04, 2025

The ADAMTS2 metalloproteinase inhibits tumor growth by regulating the innate immune system.

The ADAMTS2 metalloproteinase inhibits tumor growth by regulating the innate immune system.

Journal: Cancer cell international

Published: March 10, 2025

RANKL blockade inhibits cancer growth through reversing the tolerogenic profile of tumor-infiltrating (plasmacytoid) dendritic cells.

RANKL blockade inhibits cancer growth through reversing the tolerogenic profile of tumor-infiltrating (plasmacytoid) dendritic cells.

Journal: Journal for immunotherapy of cancer

Published: February 26, 2025

Human Papillomavirus Infection Is a Favorable Prognostic Factor for Patients With Stages I to IVA Esophageal Squamous Cell Carcinoma but not Adenocarcinoma.

Human Papillomavirus Infection Is a Favorable Prognostic Factor for Patients With Stages I to IVA Esophageal Squamous Cell Carcinoma but not Adenocarcinoma.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Published: December 11, 2024

Targeting myoferlin in ER/Golgi vesicle trafficking reprograms pancreatic cancer-associated fibroblasts.

Targeting myoferlin in ER/Golgi vesicle trafficking reprograms pancreatic cancer-associated fibroblasts.

Journal: The EMBO journal

Published: August 22, 2024

COL25A1 and METAP1D DNA methylation are promising liquid biopsy epigenetic biomarkers of colorectal cancer using digital PCR.

COL25A1 and METAP1D DNA methylation are promising liquid biopsy epigenetic biomarkers of colorectal cancer using digital PCR.

Journal: Clinical epigenetics

Published: July 08, 2024

CXCR4 Antagonist in HPV5-Associated Perianal Squamous-Cell Carcinoma.

CXCR4 Antagonist in HPV5-Associated Perianal Squamous-Cell Carcinoma.

Journal: The New England journal of medicine

Published: April 10, 2024

The 14th Afipp scientific days

The 14th Afipp scientific days

Journal: Virologie (Montrouge, France)

Published: March 07, 2024

Atezolizumab plus modified docetaxel, cisplatin, and fluorouracil as first-line treatment for advanced anal cancer (SCARCE C17-02 PRODIGE 60): a randomised, non-comparative, phase 2 study.

Atezolizumab plus modified docetaxel, cisplatin, and fluorouracil as first-line treatment for advanced anal cancer (SCARCE C17-02 PRODIGE 60): a randomised, non-comparative, phase 2 study.

Journal: The Lancet. Oncology

Published: November 07, 2023

Showing 1-12 of 80

Last Updated: 09/26/2026